Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-12

Clinical Trial Update: Safety and Bone Health Study of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis [Phase 2]

View source ↗

Summary

Phase 2 safety and bone health study of SM04690 for knee osteoarthritis has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SM04690 (SM04690)

Snippet

Sponsor: Biosplice Therapeutics, Inc. | Conditions: Knee Osteoarthritis | Phase 2 | Status: COMPLETED | Results posted: 2026-01-12